Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G02 OTHER GYNECOLOGICALS
G02C OTHER GYNECOLOGICALS
G02CX Other gynecologicals
G02CX06 Fezolinetant
D11976 Fezolinetant (USAN) <US>
USP drug classification [BR:br08302]
Central Nervous System Agents
Central Nervous System, Other
Fezolinetant
D11976 Fezolinetant (USAN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
D11976 Fezolinetant
DG01642 CYP2C9 substrate
D11976 Fezolinetant
DG01639 CYP2C19 substrate
D11976 Fezolinetant
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Tachykinin
TACR3 (NK3R)
D11976 Fezolinetant (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11976
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11976
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11976